Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SARTHAK BIOTECH PRIVATE LIMITED | 1 | ₹26,700 |
| 2 | Schedule 3 | Not yet disclosed by govt.Likely | 3 | - |
Tender Value
₹3.5 L
EMD Value
Exempted
Closing Date
14 Aug 2025, 11:00 amClosed
Itraconazole Capsule (Q2)
Acyclovir Tablets (V2) (Q2) Clindamycin Capsule (Q2)
Lamivudine Tablet (Q2) MSE Exemption for Years Of Experience Yes | Complete Startup Exemption for Years Of Experience Yes | Complete -- Minimum number of bids required to disable automatic bid extension 1
-- Number of days for which Bid would be auto -- extended 7 Bid to RA enabled Yes RA Qualification Rule H1-Highest Priced Bid Elimination Type of Bid Two Packet Bid Primary product category Lamivudine Tablet Time allowed for Technical Clarifications during technical evaluation 2 Days ( )/Inspection Required (By Empanelled Inspection Authority Agencies pre-registered with GeM) No Estimated Bid Value 354344 Evaluation Method Item wise evaluation Bid Document 1/19 Arbitration Clause No Mediation Clause No Bid Details EMD Detail Required No ePBG Detail Required No Splitting
8156386
GEM/2025/B/6511944
Two Packet Bid
Lamivudine Tablet
GeM Contract
Chandigarh; Chandigarh
Item wise evaluation
PRODUCT
Awarded to SARTHAK BIOTECH PRIVATE LIMITED
₹26,700
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Itrasar 100--SARTHAK BIOTECH PRIVATE LIMITED Itraconazole Capsule 100 mg | Itrasar 100--SARTHAK BIOTECH PRIVATE LIMITED / ITRACONAZOLE 100 CAPSULE 10x10 BLISTER | HSN not specified by seller | 15,000 capsule(s) | 1.78 | 26,700 |
Awarded to SARTHAK BIOTECH PRIVATE LIMITED
₹2,200
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Clarisar 500--SARTHAK BIOTECH PRIVATE LIMITED Clarithromycin Tablet 500 mg | Clarisar 500--SARTHAK BIOTECH PRIVATE LIMITED / 10x1x10 | HSN not specified by seller | 200 tablet(s) | 11 | 2,200 |
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Itraconazole Capsule (Q2) | - | - | - |
| Acyclovir Tablets (V2) (Q2) Clindamycin Capsule (Q2) | - | - | - |
| Lamivudine Tablet (Q2) | - | - | - |
Exempted
28 Oct 2025
14 Aug 2025
14 Aug 2025
contract_GEMC-511687763749924.pdf
GEM_CONTRACT • 0.09 MB
contract_GEMC-511687721468265.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8156386.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .